Non-adherent, 3-dimensional sphere formation is used as an in vitro surrogate to evaluate cellular potential for tumour initiation and self-renewal. To determine if a shared molecular program underlies the capacity for sphere formation by cells originating from diverse tumour types, we characterized molecular and functional properties of 10 independent cell lines derived from 3 ontogenetically distinct dog cancers: hemangiosarcoma, osteosarcoma and glial brain tumours. Genome-wide gene expression profiling identified tumour-of-origin-dependent patterns of adjustment to sphere formation in a uniform culture condition. However, expression of the stem/progenitor markers CD34 and CD117, resistance to cytotoxic drugs and dye efflux (side population assays) showed no association with these gene expression profiles.
| INTRODUCTION
The properties that endow cells with tumour-initiating and selfrenewal capacity have been the subject of extensive investigation. 1 Tumour-initiating cells (TICs, also known as cancer stem cells) promote an organizational hierarchy that is critical for self-renewal and, consequently, tumour progression. Several cell surface markers and functional assays have been proposed to identify TICs in vitro in haematopoietic and solid tumours. [2] [3] [4] [5] However, TICs show extensive intra-and inter-tumour heterogeneity, and a universal set of markers has not been identified to broadly define these cells. 4 TICs can be defined functionally, and since the original reports showing that adult neural stem cells were enriched by formation of non-adherent, 3-dimensional spheres under serum-free conditions, 6 sphere-forming assays have been used as an in vitro tool to enrich putative TICs. 5, 7, 8 Still, sphere cells also are variable among different tumours, and common features have not been standardized.
Here, we investigated if sphere-forming cells from 3 distinct cancer types had shared molecular programs using a genome-wide gene expression microarray platform to enable hypothesis generation. We included dog cell lines derived from hemangiosarcoma (HSA), osteosarcoma (OS) and glial brain tumours to study functional, biochemical, molecular and morphological events associated with formation and maintenance of tumour cell-derived spheres in culture. Our data suggest that modulation of gene clusters that regulate metabolic and immunosuppressive functions is a consistent feature of sphereforming cells from these tumours.
| MATERIALS AND METHODS

| Samples
Samples were collected from client-owned dogs with naturally occurring HSA, OS and glial brain tumours. Informed consent was obtained from all dog owners prior to the sample collection. The process of collection and generation for some of the cell lines used has been described previously (see below). For all new samples used in this study, collection protocols were approved and reviewed by the Insti- 
| Sphere-forming efficiency assays
| Surface marker staining and DyeCycle Violet dye-efflux assays
Surface marker expression and DyeCycle Violet dye-efflux assays were performed by flow cytometry as described. 18, 19 The primary antibodies used for surface markers staining were: anti-CD117-PE (cKit) and anti-CD34-PE (eBioscience, San Diego, California). Fifty thousand events per sample were collected on a BD FACSCalibur (BD Biosciences, San Jose, California). Dye-Cycle violet emission was detected using 450/50 nm band-pass (blue) and 650 nm long-pass (red) filters in response to excitation by a violet diode laser (405 nm) using a BD LSR II flow cytometer (BD Biosciences). Propidium iodide was added to each sample immediately before collection to exclude dead cells from analysis. Data were analysed using FlowJo software (Tree Star Inc., Ashland, Oregon).
| Chemosensitivity assays
Chemosensitivity of monolayer and sphere cells was determined (Tables S1-S3 ). These data suggest that cells from these 3 tumour types preserved unique ontogenetic and biological features through the process of sphere formation.
| Statistics and data visualization
| The sphere-forming efficiency of dog cancer cell lines is inversely proportional to primary sphere formation
All cancer cell lines used in this study successfully formed spheres and re-formed monolayers, indicating that sphere formation and sphere cell maintenance were reversible processes ( Figure S1 ). Both the total number of spheres formed and the kinetics of sphere formation were variable among the cell lines. We therefore examined 
| The relationship among different traits associated with functions of TICs is conserved in spheres from different dog cancer cell lines
The phenotypic markers CD34 and CD117 have been used to identify putative TICs in haematopoietic and also in some mesenchymal cancers. 17, [22] [23] [24] Our flow cytometry results showed increased CD34 or CD117 expression in spheres compared with monolayer cells for some of the cell lines; however, this was not observed in all of the cell lines we tested (Table S4 and Figure S2 ). Drug resistance is another feature that has been used to identify and enrich TICs from both human and dog cancers. 19, 25, 26 As was true for expression of CD34 and CD117, sphere cells from some of the tumour cell lines were more resistant to doxorubicin and paclitaxel than their corresponding monolayer cells, but others were not (Table S5) Figure 3 . The data indicate statistically significant negative correlations (P < .01) between primary sphere formation and sphere-forming efficiency and between primary sphere formation and verapamil-resistant dye efflux. In addition, secondary sphere formation was negatively correlated (P < .05) with in vitro drug resistance. Conversely, CD34 expression was positively correlated (P < .05) with sphere-forming efficiency, and resistance to doxorubicin was positively correlated (P < .05) with resistance to paclitaxel, suggesting that sphere cells engage common mechanisms of drug resistance. However, neither total dye efflux nor verapamilresistant dye efflux showed consistent correlations with drug resistance in the sphere cells, suggesting that these properties are not mechanistically linked.
| Cancer cell metabolism and immune programs are associated with sphere formation
Finally, we sought to identify molecular mechanisms that contribute to sphere-forming capacity. For this purpose, we compared cell lines with the highest (SB, Frog and GRCR) and the lowest (Emma, CADE and MARO) sphere-forming efficiency ( Figure 4A ). Primary spheres generated from these cell lines were cultured under identical conditions to minimize potential contributions from the cell culture Mann-Whitney test (*P < .05; **P < .01; ****P < .0001). C, Relative sphereforming efficiencies (the ratio of secondary sphere formation relative to primary sphere formation) (Spearman r = −.78; P = .009) Figure S4 , and Table S7 ).
Upstream regulators of these genes were predicted to activate IL10RA and RARA and also to inhibit RIPK2, STAT6, SMARCA4 and several cytokines such as IFNG, IL-6, OSM and IL1B ( Figure 4B and Table S8 ). The profile analysis also identified the top significant canonical pathways associated with fatty acid metabolism and immune signalling, including ACSL1 and ACSL5, FASN and CD40
genes. Figure 5 displays a summary of the results, including a hypothetical model proposing that the core molecular systems, which into lineage-committed cells, 34, 35 and that fatty acid oxidation maintains quiescence of haematopoietic stem cells to prevent them from exhaustion. 36, 37 Thus, a model has been proposed where a potential shift from a fatty acid oxidation-dominant phenotype to a fatty acid synthesis-dominant phenotype determines the transition from quiescent, normal stem cells to proliferating, normal progenitor cells. 35, 36 A similar process might be operative in cancer cells that require metabolic reprogramming to regulate stemness and self-renewal, 38, 39 since emerging data suggest that metabolic reprogramming can be In conclusion, we demonstrate that 10 cancer cell lines derived from 3 distinct dog tumour types preserve their ontogenetic transcriptional profiles in uniform in vitro culture conditions. By utilizing primary and secondary sphere-forming assays combined with genome-wide gene expression profiling, we found that sphere- 
